<p>Co-expression of EGFR, HER-2, HER-3, and HER-4 in a formalin fixed paraffin embedded tumour sections stained immunohistochemically as described under methods and patients section. Magnification: ×200.</p
The epidermal growth factor receptor (EGFR) is often aberrantly expressed in colorectal cancer, and ...
Epidermal growth factor (EGF) receptor expression was estimated in 50 invasive human colorectal canc...
Colorectal cancer (CRC) is the third most common cancer worldwide and the second leading cancer in M...
<p>Immunostaining of EGFR 3+, HER-2 3+, HER-3 2+, and HER-4 3+ in formalin fixed paraffin embedded t...
The human epidermal growth factor receptor (EGFR) is an important therapeutic target in patients wit...
The human epidermal growth factor receptor (EGFR) is an important therapeutic target in patients wit...
<p>Immunohistochemical expression of HER family members in Dukes’ C and D colon cancer patients.</p
<p>Co-expression level of HER family members presented as percentage positive tumour cells immunosta...
<p>Kaplan-Meier survival curves showing the impact on the disease-free survival of the patients with...
Despite the approval of the anti-epidermal growth factor receptor (EGFR) monoclonal antibodies (mAbs...
Gastric cancer is a major cause of cancer-related deaths in both men and women. The epidermal growth...
Background: To determine the frequency of HER-2 overexpression in colorectal cancer (CRC) patients, ...
The clinical relevance of circulating tumour cells (CTC) in peripheral blood of patients with colore...
Aim: To assess and compare immunohistochemical expression of epidermal growth factor receptor EGFR w...
Background: Colorectal cancer is one of the most common causes of death in the world and third and f...
The epidermal growth factor receptor (EGFR) is often aberrantly expressed in colorectal cancer, and ...
Epidermal growth factor (EGF) receptor expression was estimated in 50 invasive human colorectal canc...
Colorectal cancer (CRC) is the third most common cancer worldwide and the second leading cancer in M...
<p>Immunostaining of EGFR 3+, HER-2 3+, HER-3 2+, and HER-4 3+ in formalin fixed paraffin embedded t...
The human epidermal growth factor receptor (EGFR) is an important therapeutic target in patients wit...
The human epidermal growth factor receptor (EGFR) is an important therapeutic target in patients wit...
<p>Immunohistochemical expression of HER family members in Dukes’ C and D colon cancer patients.</p
<p>Co-expression level of HER family members presented as percentage positive tumour cells immunosta...
<p>Kaplan-Meier survival curves showing the impact on the disease-free survival of the patients with...
Despite the approval of the anti-epidermal growth factor receptor (EGFR) monoclonal antibodies (mAbs...
Gastric cancer is a major cause of cancer-related deaths in both men and women. The epidermal growth...
Background: To determine the frequency of HER-2 overexpression in colorectal cancer (CRC) patients, ...
The clinical relevance of circulating tumour cells (CTC) in peripheral blood of patients with colore...
Aim: To assess and compare immunohistochemical expression of epidermal growth factor receptor EGFR w...
Background: Colorectal cancer is one of the most common causes of death in the world and third and f...
The epidermal growth factor receptor (EGFR) is often aberrantly expressed in colorectal cancer, and ...
Epidermal growth factor (EGF) receptor expression was estimated in 50 invasive human colorectal canc...
Colorectal cancer (CRC) is the third most common cancer worldwide and the second leading cancer in M...
DOI
Add to ORKG